Loomba R, Neutel J, Mohseni R et al (2019) LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial
Serious risks include potential increased risk of pancreatitis, gallbladder disease, and thyroid tumors in animal studies
As insulin resistance is a hallmark of T2D, improving this parameter could translate into better overall glycaemic control for patients
They also understood that there were millions of consumers who would not pay $1,000 or even $500 per month for the product, but who would be interested if they could get to the right price point
Why use a blend instead of running BPC-157 and TB-500 from separate vials
Milk Thistle: Known for supporting liver health, milk thistle can help maintain the body's natural glutathione production